Triodos Investment Management BV Has $49.58 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Triodos Investment Management BV has increased its stake in Intuitive Surgical, Inc. by 1.4% in the second quarter, now holding shares worth approximately $49.58 million.
• Notable institutional investors including Goldman Sachs and Vanguard Group have also significantly increased their holdings in Intuitive Surgical, reflecting strong institutional interest in the company.
• Intuitive Surgical reported an earnings per share of $2.19 for the latest quarter, surpassing analysts' expectations, with revenues showing a 21.4% year-over-year increase.

Triodos Investment Management BV boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 91,237 shares of the medical equipment provider's stock after purchasing an additional 1,250 shares during the quarter. Intuitive Surgical comprises 3.7% of Triodos Investment Management BV's holdings, making the stock its 6th largest holding. Triodos Investment Management BV's holdings in Intuitive Surgical were worth $49,579,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Nuveen LLC bought a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. Goldman Sachs Group Inc. increased its holdings in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after acquiring an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after acquiring an additional 566,979 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company's stock, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $443.76 on Friday. The company has a market capitalization of $159.08 billion, a PE ratio of 61.89, a price-to-earnings-growth ratio of 4.71 and a beta of 1.61. The business has a fifty day moving average price of $459.75 and a two-hundred day moving average price of $498.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.78 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent research reports. BTIG Research restated a "buy" rating and set a $571.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 1st. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Weiss Ratings restated a "hold (c+)" rating on shares of Intuitive Surgical in a report on Wednesday. Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Finally, Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, October 4th. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $589.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.